Abstract
Objective: To investigate the potential distribution of radiolabelled botulinum neurotoxin type A (Bo NT /A) in the CNS after bladder injection in normal rats, by using the gamma‐emitting radionuclide technetium‐99 m ( 99m Tc). Materials and Methods: Bo NT /A was radiolabelled by pretreatment with 2‐iminothiolane and incubation with 99m Tc‐gluconate. The labelled toxin 99m Tc‐Bo NT /A was purified using size exclusion HPLC . Twenty‐four female Wistar rats were evenly injected in the bladder wall with either 99m Tc‐ΒοΝΤ/Α ( n = 12) or free 99m Tc ( n = 12). Four rats from each group were killed at 1, 3 and 6 h after injection, respectively. The bladder, L6‐S1 spinal cord segment and L6‐S1 dorsal root ganglia ( DRG ) were harvested and their radioactivity counted in a gamma scintillation detector. Results were calculated as % injected dose (I.D.) per gram of tissue. The paired t ‐test was used for comparison of means of 99m Tc‐ΒοΝΤ/Α radioactivity vs free 99m Tc in the tissues of interest. Results: Radiolabelled Bo NT /A had a high radiochemical stability of 70% after 24 h. Gradual accumulation of 99m Tc‐ΒοΝΤ/Α was observed in the DRG up to 6 h after injection ( P = 0.04 and P = 0.029 compared with 1 h and 3 h, respectively), while no accumulation was detected for free 99m Tc. Consequently, 99m Tc‐ΒοΝΤ/Α radioactivity in the DRG was higher than free 99m Tc radioactivity (3.18 ± 0.67% I.D./g vs 0.19 ± 0.10% I.D./g [ P = 0.002] 6 h after injection). Values for 99m Tc‐ΒοΝΤ/Α radioactivity in the spinal cord were higher than those for free 99m Tc, but not significantly. The bladder retained higher dosages of 99m Tc‐ΒοΝΤ/Α than free 99m Tc at all time points. Conclusions: Significant accumulation of the radiolabelled toxin in the lumbosacral DRG , together with a less significant uptake in the respective spinal cord segment as opposed to free radioactivity provide first evidence of the retrograde transport of Bo NT /A to the CNS after bladder injection in rats.
Funding Information
  • Pfizer
  • Coloplast
  • Astellas Pharma US

This publication has 36 references indexed in Scilit: